The biological signs and treatment of Dyslexia

Dr. Carole Samango-Sprouse has been working with young disabled children since 1982 she specializes in the neurodevelopmental assessment of children with complex medical conditions. Dr. Samango-Sprouse is trained in neuromotor and neurocognitive development, neurobehavioral skills and oral motor assessment for children with an emphasis on young children with genetic disorders. She is trained in neurodevelopmental treatment and certified in the assessment of pre-term infant behavior and the Brazelton Neonatal Assessment Scale. She is the author of more than 60 articles on the neurocognitive capabilities of atypical children, Dr. Samango-Sprouse studies the relationship between the brain and behavior, and its impact on school performance in children with neurogenetic disorders. As the director of the Neurodevelopmental Diagnostic Center for Young Children, Dr. Samango-Sprouse evaluates patients from all over the world in order to develop comprehensive and intensive intervention programs that are syndrome-specific. These programs recognize the complex interaction and intimate connection between brain, cognition, behavior, learning, and medical diagnosis. Dr. Samango-Sprouse trains and educates parents and professionals around the country and internationally to understand the complex interaction between neurodevelopmental disorders, learning and educational success. Dr. Samango-Sprouse serves one of the largest patient populations in the world of children who were prenatally diagnosed with an X & Y Chromosomal Variation. In addition, Dr. Samago-Sprouse is the founder, executive director and chief science officer of The Focus Foundation.